73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
An elusive mechanism of wasting syndrome cachexia revealed

An elusive mechanism of wasting syndrome cachexia revealed

by Justin Jackson , Medical XpressOSM induces Eda2r expression in muscle and the depletion of OSMR protects from muscle wasting. a, Mouse primary myotubes were treated with recombinant TNFα, IL-6, LIF

An elusive mechanism of wasting syndrome cachexia revealed

by Justin Jackson , Medical XpressOSM induces Eda2r expression in muscle and the depletion of OSMR protects from muscle wasting. a, Mouse primary myotubes were treated with recombinant TNFα, IL-6, LIF
Researchers reveal why obesity makes ovarian cancer more deadly

Researchers reveal why obesity makes ovarian cancer more deadly

by Brett Beasley,University of Notre DameElizabeth Harper, who received her doctorate in the Integrated Biomedical Sciences Graduate Program at the University of Notre Dame, served as a co-autho

Researchers reveal why obesity makes ovarian cancer more deadly

by Brett Beasley,University of Notre DameElizabeth Harper, who received her doctorate in the Integrated Biomedical Sciences Graduate Program at the University of Notre Dame, served as a co-autho
Current PSA monitoring ignores risk to some prostate cancer survivors

Current PSA monitoring ignores risk to some prostate cancer survivors

by Scott Maier,University of California, San FranciscoCredit: University of California, San FranciscoProstate cancer survivors make up the largest group, 41 percent, of male cancer survivors. In

Current PSA monitoring ignores risk to some prostate cancer survivors

by Scott Maier,University of California, San FranciscoCredit: University of California, San FranciscoProstate cancer survivors make up the largest group, 41 percent, of male cancer survivors. In
ASH: A+AVD beats ABVD for advanced Hodgkin's lymphoma

ASH: A+AVD beats ABVD for advanced Hodgkin's lymphoma

(HealthDay)—For patients with advanced-stage Hodgkin's lymphoma, brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine (A+AVD) have superior efficacy to doxorubicin, bleomycin, vinblastin

ASH: A+AVD beats ABVD for advanced Hodgkin's lymphoma

(HealthDay)—For patients with advanced-stage Hodgkin's lymphoma, brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine (A+AVD) have superior efficacy to doxorubicin, bleomycin, vinblastin
Blood-borne cancer detection receives gold-plated boost

Blood-borne cancer detection receives gold-plated boost

by Lachlan Gilbert,University of New South WalesA computer representation of the gold coated nanoparticles that make up the dispersible electrodes. These are modified with DNA that gives an elec

Blood-borne cancer detection receives gold-plated boost

by Lachlan Gilbert,University of New South WalesA computer representation of the gold coated nanoparticles that make up the dispersible electrodes. These are modified with DNA that gives an elec
Team discovers gene mutations linked to pancreatic cancer

Team discovers gene mutations linked to pancreatic cancer

by Susan Buckles,Mayo ClinicCredit: Mayo ClinicSix genes contain mutations that may be passed down in families, substantially increasing a person's risk for pancreatic cancer. That's acc

Team discovers gene mutations linked to pancreatic cancer

by Susan Buckles,Mayo ClinicCredit: Mayo ClinicSix genes contain mutations that may be passed down in families, substantially increasing a person's risk for pancreatic cancer. That's acc
Cancer-predisposition variants associated with adverse outcomes in rhabdomyosarcoma

Cancer-predisposition variants associated with adverse outcomes in rhabdomyosarcoma

by Molly Chiu,Baylor College of MedicineKaplan-Meier Survival Outcomes of Cancer-Predisposition Variant (CPV) Status on Rhabdomyosarcoma (RMS). Credit:JAMA Network Open(2024). DOI: 1

Cancer-predisposition variants associated with adverse outcomes in rhabdomyosarcoma

by Molly Chiu,Baylor College of MedicineKaplan-Meier Survival Outcomes of Cancer-Predisposition Variant (CPV) Status on Rhabdomyosarcoma (RMS). Credit:JAMA Network Open(2024). DOI: 1
'Google Maps' for cancer: Image-based computer model reveals finer details of tumor blood flow

'Google Maps' for cancer: Image-based computer model reveals finer details of tumor blood flow

by Johns Hopkins University School of MedicineGoogle Maps for cancer. Credit: Johns Hopkins MedicineJohns Hopkins Medicine researchers say they have developed something akin to a "Google Map

'Google Maps' for cancer: Image-based computer model reveals finer details of tumor blood flow

by Johns Hopkins University School of MedicineGoogle Maps for cancer. Credit: Johns Hopkins MedicineJohns Hopkins Medicine researchers say they have developed something akin to a "Google Map
Finding and targeting a tumor's sweet spot to eradicate aggressive form of leukemia

Finding and targeting a tumor's sweet spot to eradicate aggressive form of leukemia

byUniversity of BirminghamCredit:Cell Reports(2023). DOI: 10.1016/j.celrep.2023.113568A highly aggressive common form of leukemia which is activated by mutations in signaling molecul

Finding and targeting a tumor's sweet spot to eradicate aggressive form of leukemia

byUniversity of BirminghamCredit:Cell Reports(2023). DOI: 10.1016/j.celrep.2023.113568A highly aggressive common form of leukemia which is activated by mutations in signaling molecul
Metalloimmunotherapy: Combination of cisplatin and STING agonist into one molecule boosts cancer immune response

Metalloimmunotherapy: Combination of cisplatin and STING agonist into one molecule boosts cancer immune response

by Science China PressSchematic illustration of the construction of conjugates I and II. Schematic illustration of the combinational effects on tumors of the PtIV-MSA-2 conjugates. The PtIV-MSA-2

Metalloimmunotherapy: Combination of cisplatin and STING agonist into one molecule boosts cancer immune response

by Science China PressSchematic illustration of the construction of conjugates I and II. Schematic illustration of the combinational effects on tumors of the PtIV-MSA-2 conjugates. The PtIV-MSA-2
Altered cell behavior behind resistance in neuroblastoma

Altered cell behavior behind resistance in neuroblastoma

byLund UniversityEstablishment and application of a COJEC-like treatment protocol using NB PDX models.(A) Schematic representation of the experimental design. Mice were injected subcutaneously (

Altered cell behavior behind resistance in neuroblastoma

byLund UniversityEstablishment and application of a COJEC-like treatment protocol using NB PDX models.(A) Schematic representation of the experimental design. Mice were injected subcutaneously (
Early-stage cancer diagnoses decreased sharply in the US during first year of COVID-19 pandemic

Early-stage cancer diagnoses decreased sharply in the US during first year of COVID-19 pandemic

by American Cancer SocietyCOVID-19 and Cancer. Credit: American Cancer SocietyA new study from researchers at the American Cancer Society (ACS) found monthly adult cancer diagnoses decreased by h

Early-stage cancer diagnoses decreased sharply in the US during first year of COVID-19 pandemic

by American Cancer SocietyCOVID-19 and Cancer. Credit: American Cancer SocietyA new study from researchers at the American Cancer Society (ACS) found monthly adult cancer diagnoses decreased by h